Gaxos.ai targets scalable AI apps, RNK Health to drive recurring revenue growth
GXAI•Post-divestiture plan focuses on recurring revenue
Gaxos said it has set a post-divestiture plan to concentrate resources on revenue-generating AI applications from Gaxos Labs and RNK Health wellness products.
The strategy targets faster recurring revenue growth, tighter customer-acquisition payback, disciplined capital deployment, and clearer investor messaging.
Gaxos Labs to push commercially oriented AI products
Gaxos Labs will focus on commercially oriented products, led by an AWS-supported AI sales coaching platform with real-time transcription and post-call analytics.
Reporting to expand as gaming exit leaves minority stake
Investor reporting is set to expand to include additional operating performance indicators where reliably measurable.
The gaming exit leaves strategic exposure via a 19.99% stake in America First Defense.AI, which will be reported separately from consolidated operations.
